Institute for Systems Biology was founded in 2004.
The main activity is the application of mathematical modeling for pharmacology, personal medicine, and biotechnology. The ISB innovative approach has become an integral part of the drug development process implemented by our strategic partners.
Today, the company has more than 30 qualified specialists, collaborates with leading pharmacological companies, works with students and postgraduates, has published a number of scientific reports and presented at mejor international conferences. In addition, our business is not limited to only mathematical modeling; ISB develops software for specialists in systems pharmacology and systems biology.
PIQ-PHARMA is one of the first innovative pharmaceutical companies of Russia. Our activities are directed towards development and practical application of modern medical products with the purpose of providing doctors and patients with effective means of treatment and prevention of diseases.
The company includes departments for development, registration, promotion and sale of modern effective medical products.
Since its establishment in 1994, PIQ-PHARMA has been working together with research centers, supporting promising scientific research projects in Russian biochemistry and pharmacology. Basing on the research results, the company creates and brings to the final consumer highly effective means of treatment and prevention of diseases.
The company has its own production base, conforming to the European quality standards for pharmaceutical production.
MZKRS suture materials LLC is a leading Russian manufacturer of surgical suture material, member of the Russian Association “Rosmedprom”, the Moscow Chamber of Commerce, and the Guild of medical-care product manufactures, holder of the Moscow Reliable Company Certificate and the 1st-Grade Laureate of «Moscow Quality 2012» Award.
The company was founded in 2000 and has a long history of manufacturing and supplying surgical suture materials to more than 64 regions of Russian Federation, Ukraine, Kazakhstan and Belorussia.
It has a number of production sites in Moscow and several other regions of Russia, producing more than 2 million product units per year.
The company was the first in Russia to begin introducing fluorescent detection of PCR products in laboratory tests on a large scale, using both a variety of reagent sets and its own made-up equipment.
Today the FLASH technology has become popular not only in Russia but also worldwide. One of Russia's first real-time thermocyclers was developed, introduced into practice and registered by DNA-Technology. The mobile PCR-laboratory developed by the Company is unique in its kind.
For its achievements the Company received awards at the 3-rd international congress 'Biotechnology: "Current State and Development Prospect", by the Moscow Regional Duma, The Rear Echelon Directorate of the Armed Forces.
DNA-Technology plans to continue developing advanced science and technologies and expand cooperation with scientific and clinical institutions. The Company actively cooperates with leading experts in PCR and molecular biology to keep abreast of the latest science and technology developments not only in Russia but also in the rest of the world.